#aveona-therapeutics (1 Posts)
-
FDA Approves $3.1M Gene Therapy for Rare, Painful Skin Disorder The FDA has approved Zevaskyn for treating recessive dystrophic epidermolysis bullosa, a rare skin condition, promising improved healing.
Hot Topics